Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo

Cardiology

Volumn 112, Issue 3, 2009, Pages 180-187

  Hong, Chang Ming ^a   Zheng, Qiang Sun ^a   Liu, Xiong Tao ^a   Shang, Fu Jun ^a   Wang, Hong Tao ^a   Jiang, Wen Rui ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Atrial fibrosis; Dilated cardiomyopathy; M2 muscarinic acetylcholine receptor; Muscarinic gated atrial potassium channel

Indexed keywords

ACETYLCHOLINE ACTIVATED POTASSIUM CHANNEL; ANTIBODY; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; M2 MUSCARINIC RECEPTOR ANTIBODY; POTASSIUM CHANNEL; PROTEIN GIRK1; PROTEIN GIRK4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ATRIUM; IMMUNIZATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ATRIAL FIBRILLATION; AUTOANTIBODIES; ELECTRIC STIMULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HEART ATRIA; IMMUNIZATION; MYOCARDIUM; RABBITS; RECEPTOR, MUSCARINIC M2; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; RNA, MESSENGER;

EID: 48049106682     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149152     Document Type: Article

References (21)

1. Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, Hjalmarson A, Hoebeke J: Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993;91:1964-1968.
2. Sterin-Borda L, Gorelik G, Borda E: Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin Immunol Immunopathol 1991;61:389-397.
3. Mijares A, Verdot L, Peineau N, Vray B, Hoebeke J, Argibay J: Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol Cell Biochem 1996;163:107-112.
4. Goin JC, Borda E, Leiros CP, Storino R, Sterin-Borda L: Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst 1994;47:45-52.
5. de Oliveira SF, Pedrosa RC, Nascimento JH, Campos de Carvalho AC, Masuda MO: Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 1997;96:2031-2037.
6. Kannel WB, Wolf PA, Benjamin EJ, Levy D: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
7. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M: Autoantibodies against M2 muscarinic receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004;25:1108-1115.
8. Wang H, Han H, Zhang L, Shi H, Schram G, Nattel S, Wang Z: Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 2001;59:1029-1036.
9. Fu ML, Schulze W, Wallukat G, Hjalmarson A, Hoebeke J: A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin Immunol Immunopathol 1996;78:203-207.
10. Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, Kaneko S, Aizawa T, Fu LT: What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006;17:890-894.
11. Zhao R, Wang W, Wu B, Hoebeke J, Hjalmarson A, Fu ML: Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem 1996;164:185-193.
12. Moe GK: On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
13. Nunain SO, Garratt C, Paul V, Debbas N, Ward DE, Camm AJ: Effect of intravenous adenosine on human atrial and ventricular repolarisation. Cardiovasc Res 1992;26:939-943.
14. K,ACh in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 2001;37:2136-2143.
15. Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson A: Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997;29:641-655.
16. 1 adrenergic receptor coding plasmids impair cardiac function in mice. J Mol Cell Cardiol 2005;38:703-714.
17. i alpha-2 in human end-stage heart failure. Circ Res 1992;70:688-696.
18. Vatner DE, Sato N, Galper JB, Vatner SF: Physiological and biochemical evidence for coordinate increases in muscarinic receptors and G i during pacing-induced heart failure. Circulation 1996;94:102-107.
19. i-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci USA 2000;97:4826-4831.
20. Li D, Fareh S, Leung TK, Nattel S: Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100:87-95.
21. Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G, Kottkamp H, Dhein S: Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004;90:400-405.